nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—Cisplatin—lung cancer	0.343	1	CbGbCtD
Cysteamine—SST—respiratory system—lung cancer	0.0114	0.196	CbGeAlD
Cysteamine—SST—epithelium—lung cancer	0.0095	0.164	CbGeAlD
Cysteamine—SST—bronchus—lung cancer	0.00936	0.161	CbGeAlD
Cysteamine—SST—trachea—lung cancer	0.0084	0.145	CbGeAlD
Cysteamine—MPO—respiratory system—lung cancer	0.00458	0.079	CbGeAlD
Cysteamine—SST—lymph node—lung cancer	0.00413	0.0713	CbGeAlD
Cysteamine—MPO—epithelium—lung cancer	0.00383	0.066	CbGeAlD
Cysteamine—MPO—bone marrow—lung cancer	0.00268	0.0463	CbGeAlD
Cysteamine—MPO—lung—lung cancer	0.00243	0.042	CbGeAlD
Cysteamine—MPO—lymph node—lung cancer	0.00166	0.0287	CbGeAlD
Cysteamine—SST—GPCR downstream signaling—ADCY1—lung cancer	0.000645	0.00259	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—lung cancer	0.000642	0.00258	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000641	0.00258	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—JUN—lung cancer	0.00063	0.00253	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GNG11—lung cancer	0.000624	0.00251	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL8—lung cancer	0.000624	0.00251	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN2A—lung cancer	0.000624	0.00251	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADCY1—lung cancer	0.000618	0.00248	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000615	0.00247	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—lung cancer	0.000612	0.00246	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—PTEN—lung cancer	0.00061	0.00245	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—COL4A2—lung cancer	0.000602	0.00242	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTHLH—lung cancer	0.000599	0.00241	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL8—lung cancer	0.000598	0.0024	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CD4—lung cancer	0.000588	0.00236	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GIPR—lung cancer	0.000587	0.00236	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADCY1—lung cancer	0.000585	0.00235	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—lung cancer	0.000583	0.00234	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—EP300—lung cancer	0.000581	0.00234	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—COL4A2—lung cancer	0.000577	0.00232	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PTHLH—lung cancer	0.000575	0.00231	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PPP2R1B—lung cancer	0.00057	0.00229	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ANXA1—lung cancer	0.000563	0.00226	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GIPR—lung cancer	0.000562	0.00226	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—lung cancer	0.000562	0.00226	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADCY1—lung cancer	0.000561	0.00225	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SDC4—lung cancer	0.000548	0.0022	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PPP2R1B—lung cancer	0.000547	0.0022	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTHLH—lung cancer	0.000544	0.00219	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ANXA1—lung cancer	0.00054	0.00217	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DUSP3—lung cancer	0.000537	0.00216	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—APP—lung cancer	0.000534	0.00215	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CCND1—lung cancer	0.000527	0.00212	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RHEB—lung cancer	0.000526	0.00211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SDC4—lung cancer	0.000525	0.00211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTHLH—lung cancer	0.000522	0.0021	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DUSP3—lung cancer	0.000514	0.00207	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—APP—lung cancer	0.000512	0.00206	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ANXA1—lung cancer	0.000512	0.00206	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN1A—lung cancer	0.00051	0.00205	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RHEB—lung cancer	0.000505	0.00203	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM8—lung cancer	0.000499	0.002	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000496	0.00199	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ANXA1—lung cancer	0.000491	0.00197	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—POMC—lung cancer	0.000488	0.00196	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—lung cancer	0.000487	0.00195	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—EP300—lung cancer	0.000485	0.00195	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—APP—lung cancer	0.000485	0.00195	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SKI—lung cancer	0.000483	0.00194	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM8—lung cancer	0.000478	0.00192	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000476	0.00191	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—lung cancer	0.000474	0.0019	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—POMC—lung cancer	0.000468	0.00188	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—APP—lung cancer	0.000465	0.00187	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SKI—lung cancer	0.000463	0.00186	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—NRAS—lung cancer	0.000454	0.00182	CbGpPWpGaD
Cysteamine—Anorexia—Gemcitabine—lung cancer	0.000442	0.00126	CcSEcCtD
Cysteamine—Vomiting—Vinblastine—lung cancer	0.000442	0.00126	CcSEcCtD
Cysteamine—Dizziness—Erlotinib—lung cancer	0.000442	0.00126	CcSEcCtD
Cysteamine—Anaemia—Paclitaxel—lung cancer	0.00044	0.00126	CcSEcCtD
Cysteamine—Agitation—Paclitaxel—lung cancer	0.000437	0.00125	CcSEcCtD
Cysteamine—Headache—Vinblastine—lung cancer	0.000435	0.00124	CcSEcCtD
Cysteamine—Leukopenia—Etoposide—lung cancer	0.000434	0.00124	CcSEcCtD
Cysteamine—Anaphylactic shock—Cisplatin—lung cancer	0.000432	0.00123	CcSEcCtD
Cysteamine—Vomiting—Topotecan—lung cancer	0.000429	0.00122	CcSEcCtD
Cysteamine—Lethargy—Doxorubicin—lung cancer	0.000427	0.00122	CcSEcCtD
Cysteamine—Leukopenia—Paclitaxel—lung cancer	0.000426	0.00122	CcSEcCtD
Cysteamine—Rash—Topotecan—lung cancer	0.000426	0.00121	CcSEcCtD
Cysteamine—Hypersensitivity—Vinorelbine—lung cancer	0.000425	0.00121	CcSEcCtD
Cysteamine—Dermatitis—Topotecan—lung cancer	0.000425	0.00121	CcSEcCtD
Cysteamine—Vomiting—Erlotinib—lung cancer	0.000425	0.00121	CcSEcCtD
Cysteamine—Nervous system disorder—Cisplatin—lung cancer	0.000424	0.00121	CcSEcCtD
Cysteamine—Somnolence—Irinotecan—lung cancer	0.000423	0.00121	CcSEcCtD
Cysteamine—Headache—Topotecan—lung cancer	0.000423	0.00121	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—MYC—lung cancer	0.000423	0.0017	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—lung cancer	0.000421	0.00169	CbGpPWpGaD
Cysteamine—Rash—Erlotinib—lung cancer	0.000421	0.0012	CcSEcCtD
Cysteamine—Dermatitis—Erlotinib—lung cancer	0.000421	0.0012	CcSEcCtD
Cysteamine—Convulsion—Etoposide—lung cancer	0.000421	0.0012	CcSEcCtD
Cysteamine—Skin disorder—Cisplatin—lung cancer	0.00042	0.0012	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PXN—lung cancer	0.00042	0.00169	CbGpPWpGaD
Cysteamine—Dyspepsia—Irinotecan—lung cancer	0.000419	0.0012	CcSEcCtD
Cysteamine—Hypertension—Etoposide—lung cancer	0.000419	0.0012	CcSEcCtD
Cysteamine—Immune system disorder—Docetaxel—lung cancer	0.000419	0.00119	CcSEcCtD
Cysteamine—Headache—Erlotinib—lung cancer	0.000418	0.00119	CcSEcCtD
Cysteamine—Pain in extremity—Doxorubicin—lung cancer	0.000418	0.00119	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—lung cancer	0.000416	0.00167	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AVP—lung cancer	0.000415	0.00167	CbGpPWpGaD
Cysteamine—Asthenia—Vinorelbine—lung cancer	0.000414	0.00118	CcSEcCtD
Cysteamine—Decreased appetite—Irinotecan—lung cancer	0.000414	0.00118	CcSEcCtD
Cysteamine—Nausea—Vinblastine—lung cancer	0.000413	0.00118	CcSEcCtD
Cysteamine—Somnolence—Gemcitabine—lung cancer	0.000412	0.00118	CcSEcCtD
Cysteamine—Convulsion—Paclitaxel—lung cancer	0.000412	0.00118	CcSEcCtD
Cysteamine—Anorexia—Cisplatin—lung cancer	0.000412	0.00118	CcSEcCtD
Cysteamine—Affect lability—Doxorubicin—lung cancer	0.000411	0.00117	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000411	0.00117	CcSEcCtD
Cysteamine—Hypertension—Paclitaxel—lung cancer	0.000411	0.00117	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GRP—lung cancer	0.000411	0.00165	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKR1C1—lung cancer	0.000411	0.00165	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—OXTR—lung cancer	0.000411	0.00165	CbGpPWpGaD
Cysteamine—Fatigue—Irinotecan—lung cancer	0.000411	0.00117	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00041	0.00117	CcSEcCtD
Cysteamine—Discomfort—Etoposide—lung cancer	0.000408	0.00117	CcSEcCtD
Cysteamine—Constipation—Irinotecan—lung cancer	0.000407	0.00116	CcSEcCtD
Cysteamine—Mental disorder—Docetaxel—lung cancer	0.000406	0.00116	CcSEcCtD
Cysteamine—Malnutrition—Docetaxel—lung cancer	0.000403	0.00115	CcSEcCtD
Cysteamine—Erythema—Docetaxel—lung cancer	0.000403	0.00115	CcSEcCtD
Cysteamine—Decreased appetite—Gemcitabine—lung cancer	0.000403	0.00115	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000402	0.00115	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PXN—lung cancer	0.000402	0.00162	CbGpPWpGaD
Cysteamine—Nausea—Topotecan—lung cancer	0.000401	0.00114	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.0004	0.00114	CcSEcCtD
Cysteamine—Discomfort—Paclitaxel—lung cancer	0.0004	0.00114	CcSEcCtD
Cysteamine—Fatigue—Gemcitabine—lung cancer	0.0004	0.00114	CcSEcCtD
Cysteamine—Confusional state—Etoposide—lung cancer	0.000399	0.00114	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AVP—lung cancer	0.000398	0.0016	CbGpPWpGaD
Cysteamine—Constipation—Gemcitabine—lung cancer	0.000397	0.00113	CcSEcCtD
Cysteamine—Nausea—Erlotinib—lung cancer	0.000397	0.00113	CcSEcCtD
Cysteamine—Anaphylactic shock—Etoposide—lung cancer	0.000396	0.00113	CcSEcCtD
Cysteamine—Mood swings—Doxorubicin—lung cancer	0.000396	0.00113	CcSEcCtD
Cysteamine—Diarrhoea—Vinorelbine—lung cancer	0.000395	0.00113	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—AKR1C1—lung cancer	0.000394	0.00158	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRP—lung cancer	0.000394	0.00158	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—OXTR—lung cancer	0.000394	0.00158	CbGpPWpGaD
Cysteamine—Ataxia—Doxorubicin—lung cancer	0.000393	0.00112	CcSEcCtD
Cysteamine—Feeling abnormal—Irinotecan—lung cancer	0.000392	0.00112	CcSEcCtD
Cysteamine—Confusional state—Paclitaxel—lung cancer	0.000392	0.00112	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—lung cancer	0.000391	0.00157	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Irinotecan—lung cancer	0.000389	0.00111	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—lung cancer	0.000389	0.00111	CcSEcCtD
Cysteamine—Anaphylactic shock—Paclitaxel—lung cancer	0.000388	0.00111	CcSEcCtD
Cysteamine—Liver function test abnormal—Doxorubicin—lung cancer	0.000386	0.0011	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—lung cancer	0.000385	0.00155	CbGpPWpGaD
Cysteamine—Skin disorder—Etoposide—lung cancer	0.000385	0.0011	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GNG11—lung cancer	0.000385	0.00154	CbGpPWpGaD
Cysteamine—Feeling abnormal—Gemcitabine—lung cancer	0.000382	0.00109	CcSEcCtD
Cysteamine—Dizziness—Vinorelbine—lung cancer	0.000382	0.00109	CcSEcCtD
Cysteamine—Nervous system disorder—Paclitaxel—lung cancer	0.000381	0.00109	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—lung cancer	0.000381	0.00153	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—lung cancer	0.000378	0.00152	CbGpPWpGaD
Cysteamine—Anorexia—Etoposide—lung cancer	0.000378	0.00108	CcSEcCtD
Cysteamine—Skin disorder—Paclitaxel—lung cancer	0.000377	0.00108	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AVP—lung cancer	0.000377	0.00152	CbGpPWpGaD
Cysteamine—Body temperature increased—Irinotecan—lung cancer	0.000376	0.00107	CcSEcCtD
Cysteamine—Abdominal pain—Irinotecan—lung cancer	0.000376	0.00107	CcSEcCtD
Cysteamine—Decreased appetite—Cisplatin—lung cancer	0.000376	0.00107	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000373	0.00107	CcSEcCtD
Cysteamine—Anaemia—Docetaxel—lung cancer	0.000373	0.00106	CcSEcCtD
Cysteamine—Anorexia—Paclitaxel—lung cancer	0.00037	0.00106	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GNG11—lung cancer	0.000369	0.00148	CbGpPWpGaD
Cysteamine—Vomiting—Vinorelbine—lung cancer	0.000367	0.00105	CcSEcCtD
Cysteamine—Body temperature increased—Gemcitabine—lung cancer	0.000367	0.00105	CcSEcCtD
Cysteamine—SST—Signaling Pathways—VEGFC—lung cancer	0.000366	0.00147	CbGpPWpGaD
Cysteamine—Renal failure—Methotrexate—lung cancer	0.000366	0.00104	CcSEcCtD
Cysteamine—Rash—Vinorelbine—lung cancer	0.000364	0.00104	CcSEcCtD
Cysteamine—Dermatitis—Vinorelbine—lung cancer	0.000364	0.00104	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—lung cancer	0.000362	0.00146	CbGpPWpGaD
Cysteamine—Headache—Vinorelbine—lung cancer	0.000362	0.00103	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AVP—lung cancer	0.000362	0.00145	CbGpPWpGaD
Cysteamine—Leukopenia—Docetaxel—lung cancer	0.000361	0.00103	CcSEcCtD
Cysteamine—Feeling abnormal—Cisplatin—lung cancer	0.000356	0.00102	CcSEcCtD
Cysteamine—Somnolence—Etoposide—lung cancer	0.000352	0.001	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—VEGFC—lung cancer	0.000351	0.00141	CbGpPWpGaD
Cysteamine—Hypersensitivity—Irinotecan—lung cancer	0.000351	0.001	CcSEcCtD
Cysteamine—Convulsion—Docetaxel—lung cancer	0.000349	0.000997	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—lung cancer	0.000348	0.000994	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ADCY1—lung cancer	0.000346	0.00139	CbGpPWpGaD
Cysteamine—Somnolence—Paclitaxel—lung cancer	0.000345	0.000985	CcSEcCtD
Cysteamine—Decreased appetite—Etoposide—lung cancer	0.000344	0.000983	CcSEcCtD
Cysteamine—Nausea—Vinorelbine—lung cancer	0.000343	0.000979	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Etoposide—lung cancer	0.000342	0.000976	CcSEcCtD
Cysteamine—Dyspepsia—Paclitaxel—lung cancer	0.000342	0.000976	CcSEcCtD
Cysteamine—Body temperature increased—Cisplatin—lung cancer	0.000342	0.000975	CcSEcCtD
Cysteamine—Asthenia—Irinotecan—lung cancer	0.000342	0.000975	CcSEcCtD
Cysteamine—Fatigue—Etoposide—lung cancer	0.000341	0.000975	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000341	0.000973	CcSEcCtD
Cysteamine—Constipation—Etoposide—lung cancer	0.000339	0.000967	CcSEcCtD
Cysteamine—Decreased appetite—Paclitaxel—lung cancer	0.000338	0.000964	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SMARCA4—lung cancer	0.000337	0.00135	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP2R1B—lung cancer	0.000337	0.00135	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000335	0.000957	CcSEcCtD
Cysteamine—Fatigue—Paclitaxel—lung cancer	0.000335	0.000956	CcSEcCtD
Cysteamine—Asthenia—Gemcitabine—lung cancer	0.000333	0.00095	CcSEcCtD
Cysteamine—Constipation—Paclitaxel—lung cancer	0.000332	0.000948	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—lung cancer	0.000332	0.00133	CbGpPWpGaD
Cysteamine—Confusional state—Docetaxel—lung cancer	0.000332	0.000947	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ADCY1—lung cancer	0.000332	0.00133	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Methotrexate—lung cancer	0.00033	0.000941	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—lung cancer	0.000329	0.000939	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—lung cancer	0.000327	0.000934	CcSEcCtD
Cysteamine—Feeling abnormal—Etoposide—lung cancer	0.000326	0.000932	CcSEcCtD
Cysteamine—Diarrhoea—Irinotecan—lung cancer	0.000326	0.00093	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HSPB1—lung cancer	0.000325	0.00131	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Etoposide—lung cancer	0.000324	0.000924	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PPP2R1B—lung cancer	0.000323	0.0013	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SMARCA4—lung cancer	0.000323	0.0013	CbGpPWpGaD
Cysteamine—Nervous system disorder—Docetaxel—lung cancer	0.000323	0.000921	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTHLH—lung cancer	0.000321	0.00129	CbGpPWpGaD
Cysteamine—Feeling abnormal—Paclitaxel—lung cancer	0.00032	0.000913	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—lung cancer	0.00032	0.000913	CcSEcCtD
Cysteamine—Hypersensitivity—Cisplatin—lung cancer	0.000319	0.000909	CcSEcCtD
Cysteamine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000318	0.000906	CcSEcCtD
Cysteamine—Diarrhoea—Gemcitabine—lung cancer	0.000317	0.000906	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—lung cancer	0.000317	0.000904	CcSEcCtD
Cysteamine—Dizziness—Irinotecan—lung cancer	0.000315	0.000899	CcSEcCtD
Cysteamine—Urticaria—Etoposide—lung cancer	0.000315	0.000898	CcSEcCtD
Cysteamine—Anorexia—Docetaxel—lung cancer	0.000314	0.000896	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—lung cancer	0.000313	0.000894	CcSEcCtD
Cysteamine—Abdominal pain—Etoposide—lung cancer	0.000313	0.000894	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HSPB1—lung cancer	0.000312	0.00125	CbGpPWpGaD
Cysteamine—Asthenia—Cisplatin—lung cancer	0.00031	0.000885	CcSEcCtD
Cysteamine—Urticaria—Paclitaxel—lung cancer	0.000309	0.000881	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTHLH—lung cancer	0.000308	0.00124	CbGpPWpGaD
Cysteamine—Abdominal pain—Paclitaxel—lung cancer	0.000307	0.000876	CcSEcCtD
Cysteamine—Body temperature increased—Paclitaxel—lung cancer	0.000307	0.000876	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—lung cancer	0.000306	0.00123	CbGpPWpGaD
Cysteamine—Vomiting—Irinotecan—lung cancer	0.000303	0.000864	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ANXA1—lung cancer	0.000302	0.00121	CbGpPWpGaD
Cysteamine—Immune system disorder—Methotrexate—lung cancer	0.000302	0.000861	CcSEcCtD
Cysteamine—Rash—Irinotecan—lung cancer	0.0003	0.000857	CcSEcCtD
Cysteamine—Dermatitis—Irinotecan—lung cancer	0.0003	0.000856	CcSEcCtD
Cysteamine—Headache—Irinotecan—lung cancer	0.000298	0.000851	CcSEcCtD
Cysteamine—Diarrhoea—Cisplatin—lung cancer	0.000296	0.000844	CcSEcCtD
Cysteamine—Vomiting—Gemcitabine—lung cancer	0.000295	0.000842	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FLT1—lung cancer	0.000293	0.00118	CbGpPWpGaD
Cysteamine—Somnolence—Docetaxel—lung cancer	0.000293	0.000835	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—lung cancer	0.000293	0.000835	CcSEcCtD
Cysteamine—Rash—Gemcitabine—lung cancer	0.000292	0.000835	CcSEcCtD
Cysteamine—Dermatitis—Gemcitabine—lung cancer	0.000292	0.000834	CcSEcCtD
Cysteamine—Hypersensitivity—Etoposide—lung cancer	0.000292	0.000833	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—lung cancer	0.000291	0.00083	CcSEcCtD
Cysteamine—Erythema—Methotrexate—lung cancer	0.000291	0.00083	CcSEcCtD
Cysteamine—Headache—Gemcitabine—lung cancer	0.000291	0.000829	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—lung cancer	0.00029	0.00116	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ANXA1—lung cancer	0.00029	0.00116	CbGpPWpGaD
Cysteamine—Dyspepsia—Docetaxel—lung cancer	0.00029	0.000827	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NOTCH3—lung cancer	0.000287	0.00115	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APP—lung cancer	0.000287	0.00115	CbGpPWpGaD
Cysteamine—Decreased appetite—Docetaxel—lung cancer	0.000286	0.000817	CcSEcCtD
Cysteamine—Hypersensitivity—Paclitaxel—lung cancer	0.000286	0.000817	CcSEcCtD
Cysteamine—Urinary tract disorder—Doxorubicin—lung cancer	0.000286	0.000815	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000284	0.000811	CcSEcCtD
Cysteamine—Asthenia—Etoposide—lung cancer	0.000284	0.000811	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF9—lung cancer	0.000284	0.00114	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Doxorubicin—lung cancer	0.000284	0.000811	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—lung cancer	0.000284	0.00081	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—lung cancer	0.000283	0.000809	CcSEcCtD
Cysteamine—Nausea—Irinotecan—lung cancer	0.000283	0.000807	CcSEcCtD
Cysteamine—Constipation—Docetaxel—lung cancer	0.000281	0.000803	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FLT1—lung cancer	0.000281	0.00113	CbGpPWpGaD
Cysteamine—Asthenia—Paclitaxel—lung cancer	0.000279	0.000795	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—lung cancer	0.000278	0.00112	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—POMC—lung cancer	0.000276	0.00111	CbGpPWpGaD
Cysteamine—Nausea—Gemcitabine—lung cancer	0.000276	0.000786	CcSEcCtD
Cysteamine—Vomiting—Cisplatin—lung cancer	0.000275	0.000785	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—APP—lung cancer	0.000275	0.0011	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH3—lung cancer	0.000275	0.0011	CbGpPWpGaD
Cysteamine—Rash—Cisplatin—lung cancer	0.000273	0.000778	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGF9—lung cancer	0.000272	0.00109	CbGpPWpGaD
Cysteamine—Dermatitis—Cisplatin—lung cancer	0.000272	0.000777	CcSEcCtD
Cysteamine—SST—Signaling Pathways—JUNB—lung cancer	0.000271	0.00109	CbGpPWpGaD
Cysteamine—Feeling abnormal—Docetaxel—lung cancer	0.000271	0.000774	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—lung cancer	0.000271	0.000773	CcSEcCtD
Cysteamine—Gastrointestinal pain—Docetaxel—lung cancer	0.000269	0.000768	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—lung cancer	0.000269	0.000767	CcSEcCtD
Cysteamine—Diarrhoea—Paclitaxel—lung cancer	0.000266	0.000758	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—POMC—lung cancer	0.000265	0.00106	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CG—lung cancer	0.000263	0.00106	CbGpPWpGaD
Cysteamine—Dizziness—Etoposide—lung cancer	0.000262	0.000748	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—lung cancer	0.000261	0.000745	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—lung cancer	0.00026	0.000743	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—lung cancer	0.00026	0.000743	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—lung cancer	0.00026	0.000743	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—JUNB—lung cancer	0.00026	0.00104	CbGpPWpGaD
Cysteamine—Dizziness—Paclitaxel—lung cancer	0.000257	0.000733	CcSEcCtD
Cysteamine—Nausea—Cisplatin—lung cancer	0.000257	0.000733	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CD—lung cancer	0.000255	0.00102	CbGpPWpGaD
Cysteamine—Mental disorder—Doxorubicin—lung cancer	0.000253	0.000723	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—lung cancer	0.000252	0.00101	CbGpPWpGaD
Cysteamine—Convulsion—Methotrexate—lung cancer	0.000252	0.000719	CcSEcCtD
Cysteamine—Vomiting—Etoposide—lung cancer	0.000252	0.000719	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—lung cancer	0.000252	0.000718	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—lung cancer	0.000252	0.000718	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—POMC—lung cancer	0.000251	0.00101	CbGpPWpGaD
Cysteamine—Rash—Etoposide—lung cancer	0.00025	0.000713	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—lung cancer	0.00025	0.000712	CcSEcCtD
Cysteamine—Headache—Etoposide—lung cancer	0.000248	0.000708	CcSEcCtD
Cysteamine—Tension—Doxorubicin—lung cancer	0.000247	0.000705	CcSEcCtD
Cysteamine—Vomiting—Paclitaxel—lung cancer	0.000247	0.000705	CcSEcCtD
Cysteamine—SST—Signaling Pathways—STK11—lung cancer	0.000246	0.00099	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000246	0.000701	CcSEcCtD
Cysteamine—Rash—Paclitaxel—lung cancer	0.000245	0.000699	CcSEcCtD
Cysteamine—Dermatitis—Paclitaxel—lung cancer	0.000245	0.000698	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—lung cancer	0.000245	0.000698	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL6R—lung cancer	0.000245	0.000982	CbGpPWpGaD
Cysteamine—Nervousness—Doxorubicin—lung cancer	0.000244	0.000698	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CD—lung cancer	0.000244	0.000982	CbGpPWpGaD
Cysteamine—Headache—Paclitaxel—lung cancer	0.000243	0.000694	CcSEcCtD
Cysteamine—Hypersensitivity—Docetaxel—lung cancer	0.000243	0.000692	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—POMC—lung cancer	0.00024	0.000965	CbGpPWpGaD
Cysteamine—Confusional state—Methotrexate—lung cancer	0.000239	0.000683	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FOXO3—lung cancer	0.000238	0.000955	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Methotrexate—lung cancer	0.000237	0.000677	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—STK11—lung cancer	0.000236	0.000949	CbGpPWpGaD
Cysteamine—Asthenia—Docetaxel—lung cancer	0.000236	0.000674	CcSEcCtD
Cysteamine—Nausea—Etoposide—lung cancer	0.000235	0.000671	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL6R—lung cancer	0.000234	0.000942	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAP2K1—lung cancer	0.000233	0.000936	CbGpPWpGaD
Cysteamine—Nervous system disorder—Methotrexate—lung cancer	0.000233	0.000664	CcSEcCtD
Cysteamine—Anaemia—Doxorubicin—lung cancer	0.000233	0.000664	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CD—lung cancer	0.000231	0.00093	CbGpPWpGaD
Cysteamine—Agitation—Doxorubicin—lung cancer	0.000231	0.00066	CcSEcCtD
Cysteamine—Nausea—Paclitaxel—lung cancer	0.000231	0.000658	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—lung cancer	0.00023	0.000658	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FOXO3—lung cancer	0.000228	0.000916	CbGpPWpGaD
Cysteamine—Anorexia—Methotrexate—lung cancer	0.000226	0.000645	CcSEcCtD
Cysteamine—Leukopenia—Doxorubicin—lung cancer	0.000225	0.000643	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—lung cancer	0.000225	0.000643	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—MAP2K1—lung cancer	0.000223	0.000897	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AVP—lung cancer	0.000223	0.000895	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CB—lung cancer	0.000222	0.000892	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CD—lung cancer	0.000222	0.000891	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—lung cancer	0.000218	0.000622	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—lung cancer	0.000218	0.000621	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—lung cancer	0.000217	0.00062	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IGF1R—lung cancer	0.000214	0.000862	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AVP—lung cancer	0.000214	0.000858	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL8—lung cancer	0.000214	0.000858	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CB—lung cancer	0.000213	0.000856	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000213	0.000607	CcSEcCtD
Cysteamine—Discomfort—Doxorubicin—lung cancer	0.000212	0.000604	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—lung cancer	0.000211	0.000602	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HES1—lung cancer	0.000211	0.000846	CbGpPWpGaD
Cysteamine—Vomiting—Docetaxel—lung cancer	0.000209	0.000597	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—lung cancer	0.000209	0.000596	CcSEcCtD
Cysteamine—Rash—Docetaxel—lung cancer	0.000208	0.000592	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—lung cancer	0.000207	0.000592	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—lung cancer	0.000207	0.000591	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—RAF1—lung cancer	0.000207	0.00083	CbGpPWpGaD
Cysteamine—Decreased appetite—Methotrexate—lung cancer	0.000206	0.000589	CcSEcCtD
Cysteamine—Headache—Docetaxel—lung cancer	0.000206	0.000589	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—lung cancer	0.000206	0.000826	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Doxorubicin—lung cancer	0.000205	0.000586	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000205	0.000585	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—lung cancer	0.000205	0.000822	CbGpPWpGaD
Cysteamine—Fatigue—Methotrexate—lung cancer	0.000205	0.000584	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—IL2—lung cancer	0.000204	0.00082	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HES1—lung cancer	0.000202	0.000811	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CB—lung cancer	0.000202	0.00081	CbGpPWpGaD
Cysteamine—Nervous system disorder—Doxorubicin—lung cancer	0.000201	0.000575	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—lung cancer	0.0002	0.00057	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—RAF1—lung cancer	0.000198	0.000796	CbGpPWpGaD
Cysteamine—Anorexia—Doxorubicin—lung cancer	0.000196	0.000559	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—lung cancer	0.000196	0.000786	CbGpPWpGaD
Cysteamine—Nausea—Docetaxel—lung cancer	0.000196	0.000558	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—lung cancer	0.000196	0.000558	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—lung cancer	0.000194	0.000554	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCL8—lung cancer	0.000194	0.000779	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CB—lung cancer	0.000193	0.000777	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB3—lung cancer	0.000193	0.000774	CbGpPWpGaD
Cysteamine—Urticaria—Methotrexate—lung cancer	0.000188	0.000538	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—lung cancer	0.000188	0.000535	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—lung cancer	0.000188	0.000535	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—lung cancer	0.000186	0.000747	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—lung cancer	0.000185	0.000744	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB3—lung cancer	0.000185	0.000742	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TERT—lung cancer	0.000185	0.000742	CbGpPWpGaD
Cysteamine—Somnolence—Doxorubicin—lung cancer	0.000183	0.000521	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—lung cancer	0.000181	0.000516	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGFR1—lung cancer	0.000179	0.00072	CbGpPWpGaD
Cysteamine—Decreased appetite—Doxorubicin—lung cancer	0.000179	0.00051	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—lung cancer	0.000178	0.000714	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000177	0.000506	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—lung cancer	0.000177	0.000506	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TERT—lung cancer	0.000177	0.000711	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HIF1A—lung cancer	0.000177	0.000709	CbGpPWpGaD
Cysteamine—Constipation—Doxorubicin—lung cancer	0.000176	0.000501	CcSEcCtD
Cysteamine—Hypersensitivity—Methotrexate—lung cancer	0.000175	0.000499	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGFR1—lung cancer	0.000172	0.00069	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOA1—lung cancer	0.00017	0.000684	CbGpPWpGaD
Cysteamine—Asthenia—Methotrexate—lung cancer	0.00017	0.000486	CcSEcCtD
Cysteamine—Feeling abnormal—Doxorubicin—lung cancer	0.000169	0.000483	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HIF1A—lung cancer	0.000169	0.00068	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KDR—lung cancer	0.000169	0.000678	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000168	0.000479	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—APOA1—lung cancer	0.000163	0.000656	CbGpPWpGaD
Cysteamine—Urticaria—Doxorubicin—lung cancer	0.000163	0.000466	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—lung cancer	0.000162	0.000464	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—lung cancer	0.000162	0.000464	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—lung cancer	0.000162	0.000463	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KDR—lung cancer	0.000162	0.00065	CbGpPWpGaD
Cysteamine—Dizziness—Methotrexate—lung cancer	0.000157	0.000448	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PIK3CG—lung cancer	0.000156	0.000625	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIT—lung cancer	0.000156	0.000625	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APC—lung cancer	0.000156	0.000625	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NRAS—lung cancer	0.000156	0.000625	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGF—lung cancer	0.000154	0.000618	CbGpPWpGaD
Cysteamine—Hypersensitivity—Doxorubicin—lung cancer	0.000151	0.000432	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—lung cancer	0.000151	0.000431	CcSEcCtD
Cysteamine—Rash—Methotrexate—lung cancer	0.00015	0.000427	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—lung cancer	0.000149	0.000427	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—APC—lung cancer	0.000149	0.000599	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KIT—lung cancer	0.000149	0.000599	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—lung cancer	0.000149	0.000599	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—lung cancer	0.000149	0.000599	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—lung cancer	0.000149	0.000598	CbGpPWpGaD
Cysteamine—Headache—Methotrexate—lung cancer	0.000149	0.000424	CcSEcCtD
Cysteamine—SST—Signaling Pathways—POMC—lung cancer	0.000148	0.000595	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGF—lung cancer	0.000147	0.000592	CbGpPWpGaD
Cysteamine—Asthenia—Doxorubicin—lung cancer	0.000147	0.000421	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BRAF—lung cancer	0.000146	0.000587	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6R—lung cancer	0.000144	0.00058	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CREBBP—lung cancer	0.000144	0.000579	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—lung cancer	0.000143	0.000574	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—POMC—lung cancer	0.000142	0.00057	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—lung cancer	0.000142	0.000569	CbGpPWpGaD
Cysteamine—Nausea—Methotrexate—lung cancer	0.000141	0.000402	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—lung cancer	0.000141	0.000401	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—BRAF—lung cancer	0.00014	0.000563	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6R—lung cancer	0.000138	0.000556	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CREBBP—lung cancer	0.000138	0.000555	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAP2K1—lung cancer	0.000138	0.000553	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CD—lung cancer	0.000137	0.000549	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—lung cancer	0.000136	0.000546	CbGpPWpGaD
Cysteamine—Dizziness—Doxorubicin—lung cancer	0.000136	0.000388	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—lung cancer	0.000135	0.000544	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—lung cancer	0.000134	0.000538	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAP2K1—lung cancer	0.000132	0.00053	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CD—lung cancer	0.000131	0.000527	CbGpPWpGaD
Cysteamine—Vomiting—Doxorubicin—lung cancer	0.000131	0.000373	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—lung cancer	0.00013	0.000522	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—lung cancer	0.00013	0.00037	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—lung cancer	0.000129	0.000369	CcSEcCtD
Cysteamine—Headache—Doxorubicin—lung cancer	0.000129	0.000367	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—lung cancer	0.000128	0.000516	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—lung cancer	0.000123	0.000494	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MDM2—lung cancer	0.000123	0.000492	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RAF1—lung cancer	0.000122	0.00049	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—lung cancer	0.000122	0.000348	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ERBB2—lung cancer	0.000121	0.000485	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MTOR—lung cancer	0.000119	0.000479	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CB—lung cancer	0.000119	0.000479	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—lung cancer	0.000118	0.000474	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MDM2—lung cancer	0.000117	0.000472	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAF1—lung cancer	0.000117	0.00047	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—lung cancer	0.000116	0.000465	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—lung cancer	0.000115	0.00046	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CB—lung cancer	0.000114	0.000459	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MTOR—lung cancer	0.000114	0.000459	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—lung cancer	0.000114	0.000457	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—lung cancer	0.000111	0.000444	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—lung cancer	0.00011	0.000441	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—lung cancer	0.00011	0.00044	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—lung cancer	0.000109	0.00044	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—lung cancer	0.000109	0.000438	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—lung cancer	0.000109	0.000438	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—lung cancer	0.000107	0.000429	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUN—lung cancer	0.000106	0.000428	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—lung cancer	0.000106	0.000426	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—lung cancer	0.000105	0.000422	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—lung cancer	0.000105	0.000422	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—lung cancer	0.000104	0.000419	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—lung cancer	0.000104	0.000416	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1A—lung cancer	0.000103	0.000415	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—lung cancer	0.000103	0.000414	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—lung cancer	0.000102	0.000411	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUN—lung cancer	0.000102	0.00041	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—lung cancer	0.0001	0.000404	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—lung cancer	9.93e-05	0.000399	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—lung cancer	9.9e-05	0.000398	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—lung cancer	9.88e-05	0.000397	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EP300—lung cancer	9.82e-05	0.000395	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—lung cancer	9.63e-05	0.000387	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SRC—lung cancer	9.55e-05	0.000384	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EP300—lung cancer	9.42e-05	0.000378	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—lung cancer	9.3e-05	0.000374	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—lung cancer	9.21e-05	0.00037	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NRAS—lung cancer	9.19e-05	0.000369	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—lung cancer	9.16e-05	0.000368	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—lung cancer	8.92e-05	0.000358	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—lung cancer	8.83e-05	0.000355	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRAS—lung cancer	8.81e-05	0.000354	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—lung cancer	8.8e-05	0.000353	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—lung cancer	8.56e-05	0.000344	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—lung cancer	8.44e-05	0.000339	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—lung cancer	8.37e-05	0.000336	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—lung cancer	8.21e-05	0.00033	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—lung cancer	8.03e-05	0.000322	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—lung cancer	7.91e-05	0.000318	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—lung cancer	7.58e-05	0.000305	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—lung cancer	7.27e-05	0.000292	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—lung cancer	7.03e-05	0.000282	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—lung cancer	6.97e-05	0.00028	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—lung cancer	6.74e-05	0.000271	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—lung cancer	6.72e-05	0.00027	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—lung cancer	6.45e-05	0.000259	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—lung cancer	6.43e-05	0.000258	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—lung cancer	6.17e-05	0.000248	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—lung cancer	5.94e-05	0.000238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—lung cancer	5.69e-05	0.000229	CbGpPWpGaD
